Search results
Merck scraps Keytruda trial for prostate cancer after dismal interim data
Reuters via Yahoo News· 1 year agoThe interim analysis showed the therapy did not extend survival or help extend the time a patient...
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Reuters via Yahoo News· 1 year agoMerck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug...
Immunotherapy for Cancer: What Are My Options?
Verywell Health via Yahoo News· 9 months agoImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immune system's ability to find and fight cancer. Since 2010,...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 16 hours agoBioPharma Dive is testing out a new format rounding up smaller updates from around the industry. Have thoughts on what could make this type of story...
Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask
Fortune via Yahoo Finance· 1 year agoCancer vaccines—it’s a concept seemingly torn from the plot of a futuristic sci-fi movie, or from...
The Next Generation Of Cancer Vaccines Is Coming; What That Means For Moderna And Other Biotech...
Investor's Business Daily· 1 year agoStartling cancer vaccine results from Moderna could drive the company's second act and usher in the...
U.S. FDA panel to review expanded use of Merck-AstraZeneca's cancer drug
Reuters via Yahoo News· 1 year agoThe U.S. Food and Drug Administration's (FDA) committee is scheduled to meet on April 28. The...
Ambrx (AMAM) Skyrockets 102% on $2B Buyout Offer From J&J
Zacks via Yahoo Finance· 4 months agoAmbrx Biopharma AMAM signed a definitive agreement with Johnson & Johnson JNJ. Per the agreement...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 3 days agoDive Brief: AstraZeneca’s plan to reach $80 billion in sales by 2030 relies heavily on a slate of...
Q2 2023 PDS Biotechnology Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 9 months agoParticipants Frank K. Bedu-Addo; President, CEO & Director; PDS Biotechnology Corporation Lauren V. Wood; Chief Medical Officer; PDS Biotechnology Corporation Matthew C. Hill; CFO, Principal ...